Strategies to Modify the Drug Release from Pharmaceutical Systems

Strategies to Modify the Drug Release from Pharmaceutical Systems

Volumn , Issue , 2015, Pages 1-199

  Bruschi, Marcos Luciano ^a  

^a University of Maringá UEM   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DOSAGE FORMS; DRUG DELIVERY SYSTEM; DRUG RELEASE; PHARMACEUTICAL SYSTEMS; PHYSICOCHEMICAL MODEL; REFERENCE SOURCE;

DRUG DOSAGE;

EID: 84942783592     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/C2014-0-02342-8     Document Type: Book

References (251)

1. Aldridge M. Miscellaneous routes of medication administration. Medicines management: A guide for nurses 2010, 239-261. Wiley-Blackwell, Oxford. P. Jevon, E. Payne, D. Higgins, R. Endacott (Eds.).
2. Allen L.V., Popovich N.G., Ansel H.C. Ansel's pharmaceutical dosage forms and drug delivery 2011, Lippincott Williams & Wilkins, Baltimore-Philadelphia.
3. Anderson G.D., Saneto R.P. Current oral and non-oral routes of antiepileptic drug delivery. Advanced Drug Delivery Reviews 2012, 64:911-918.
4. Ashford M. Introduction to biopharmaceutics. Pharmaceutics: The science of dosage form design 2001, 213-216. Churchill Livingstone, London. 2nd ed. M.E. Aulton (Ed.).
5. Pharmaceutics: The science of dosage form design 2001, Churchill Livingstone, New York. M.E. Aulton (Ed.).
6. Bruschi M.L., Jones D.S., Panzeri H., Gremião M.P.D., De Freitas O., Lara H.G. Semisolid systems containing propolis for the treatment of periodontal disease: In vitro release kinetics, syringeability, rheological, textural, and mucoadhesive properties. Journal of Pharmaceutical Sciences 2007, 96(8):2074-2089.
7. Chugh I., Seth N., Rana A.C., Gupta S. Oral sustained release drug delivery system: An overview. International Research Journal of Pharmacy 2012, 3:57-61.
8. Collett J., Moreton C. Modified-release peroral dosage form. Pharmaceutics: The science of dosage form design 2001, 289-306. Churchill Livingstone, London. 2nd ed. M.E. Aulton (Ed.).
9. Dimasi J.A., Hansen R.W., Grabowski H.G. The price of innovation: New estimates of drug development costs. Journal of Health Economics 2003, 22:151-185.
10. FDA-Food and Drug Administration Food, drug, and cosmetic act-Pub L n° 75-717, 52 Stat. 1040 1938, U.S. Department of Health and Human Services, Silver Spring.
11. FDA-Food and Drug Administration Innovation or stagnation: Challenge and opportunity on the critical path to new medical products 2004, U.S. Department of Health and Human Services, Silver Spring.
12. Florence A.T., Attwood D. Physicochemical principles of pharmacy 2006, Pharmaceutical Press, London. 4th ed.
13. Gennaro A.R. Remington: The science and practice of pharmacy 2000, Lippincott Williams & Wilkins, Philadelphia. 20th ed.
14. Maurin M.B., Hussain A.A., Dittert L.W. Dosage form design: A physicochemical approach. Enciclopedy of pharmaceutical technology 2006, 939-947. Informa Healthcare, New York. 1st ed. J. Swarbrick (Ed.).
15. Medlicott N.J., Rathbone M.J., Tucker I.G., Holborow D.W. Delivery systems for the administration of drugs to the periodontal pocket. Advanced Drug Delivery Reviews 1994, 13:181-203.
16. Mignani S., El Kazzouli S., Bousmina M., Majoral J.P. Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview. Advanced Drug Delivery Reviews 2013, 65(10):1316-1330.
17. Panchagnula R., Thomas N.S. Biopharmaceutics and pharmacokinetics in drug research. International Journal of Pharmaceutics 2000, 201:131-150.
18. Pena S.D.J. Homo brasilis: Genetic, linguistic, historical and socioanthropologic aspects of the formation of the Brazilian people 2002, Ribeirão Preto, FUNPEC.
19. Proudfoot S., Collett J. Dosage regimens. Pharmaceutics: The science of dosage form design 2001, 275-288. Churchill Livingstone, London. 2nd ed. M.E. Aulton (Ed.).
20. Bader R.A., Putnam D.A. Engineering polymer systems for improved drug delivery 2014, Wiley, New York.
21. Boswell, G., & Scribner, R. (1973). Polylactide-drug mixtures, US Patent 3,773,919.
22. Bruschi M.L., Jones D., Panzeri H., Gremião M.P.D., De Freitas O., Jones D.S., et al. Precursor system of liquid crystalline phase containing propolis microparticles for the treatment of periodontal disease: Development and characterization. Drug Development and Industrial Pharmacy 2008, 34:267-278.
23. Bruschi M.L., Jones D., Panzeri H., Gremião M.P.D., De Freitas O., Lara E.H.G. Semisolid systems containing propolis for the treatment of periodontal disease: in vitro release kinetics, syringeability, rheological, textural, and mucoadhesive properties. Journal of Pharmaceutical Sciences 2007, 96(8):2074-2089.
24. Chien Y.W. Novel drug delivery systems 1992, Marcel Dekker, New York.
25. Collett J., Moreton C. Modified-release peroral dosage form. Pharmaceutics: The science of dosage form design 2001, 289-306. Churchill Livingstone, London. 2nd ed. M.E. Aulton (Ed.).
26. Cuchelkar V., Kopecek J. Polymer-drug conjugates. Polymers in drug delivery 2006, 155-182. Taylor & Francis, London. I. Uchegbu, A. Schatzlein (Eds.).
27. Davis F.F. The origin of PEGnology. Advanced Drug Delivery Reviews 2002, 54(4):457-458.
28. Duncan R., Cable H.C., Lloyd J.B., Rejmanova P., Kopecek J. Polymers containing enzymatically degradable bonds. 7. Design of oligopeptide side-chains in poly[n-(2-hydroxypropyl)methacrylamide] co-polymers to promote efficient degradation by lysosomal-enzymes. Macromolecular Chemistry and Physics 1983, 184:1997-2008.
29. Florence A.T. A short history of controlled drug release and an introduction. Controlled release in oral drug delivery 2011, 1-26. Springer, London. C.G. Wilson, P.J. Crowley (Eds.).
30. Folkman J., Long D.M. The use of silicone rubber as a carrier for prolonged drug therapy. Journal of Surgical Research 1964, 4:139-142.
31. Folkman J., Long D.M., Rosenbau R. Silicone rubber-A new diffusion property useful for general anesthesia. Science 1966, 154:148-149.
32. Gombotz, W., Healy, M., & Brown, L. (1991). Very low temperature casting of controlled release microspheres, US Patent 5,019,400.
33. Heilmann K. Therapeutic systems-Pattern-specific drug delivery: concept and development 1978, Thieme, Stuttgart.
34. Higuchi T. Rate of release of medicaments from ointments bases containing drugs in suspension. Journal of Pharmaceutical Sciences 1961, 50(10):874-875.
35. Higuchi W.I. Analysis of data on the medicament release from ointments. Journal of Pharmaceutical Sciences 1962, 51(8):802-804.
36. Higuchi T. Mechanism of sustained-action medication. Journal of Pharmaceutical Sciences 1963, 52(12):1145-1149.
37. Hoffman A.S. The origins and evolution of "controlled" drug delivery systems. Journal of Controlled Release 2008, 132:153-163.
38. Iwai K., Maeda H., Konno T. Use of oily contrast medium for selective drug targeting to tumor: Enhanced therapeutic effect and X-ray image. Cancer Research 1984, 44(5):2115-2121.
39. Jain K.K. Drug delivery systems - An overview. Drug delivery systems 2008, 1-50. Humana Press, Totowa. K.K. Jain (Ed.).
40. Jones D.S., Bruschi M.L., De Freitas O., Gremião M.P.D., Lara E.H.G. Rheological, mechanical and mucoadhesive properties of thermoresponsive, bioadhesive binary mixtures composed of poloxamer 407 and carbopol 934P designed as platforms for implantable drug delivery systems for use in the oral cavity. International Journal of Pharmaceutics 2009, 372:49-58.
41. Kent, J., Lewis, D., Sanders, L., & Tice, T. (1987). Microencapsulation of water soluble active polypeptides, US Patent 4,675,189.
42. Longer M.A., Middleton D.L., Robinson J.R. Conventional routes of delivery and the need for devices. Drug delivery devices: Fundamentals and applications 1988, 3-16. Marcel Dekker, New York. P. Tyke (Ed.).
43. Mathiowitz E., Chickering D., Lehr C.-M. Bioadhesive drug delivery systems-Fundamentals, novel approaches, and development 1999, Marcel Dekker, New York.
44. Maurin M.B., Hussain A.A., Dittert L.W. Dosage form design: a physicochemical approach. Enciclopedia of pharmaceutical technology 2006, 939-947. Informa Healthcare, New York. 1st. J. Swarbrick (Ed.).
45. Noyes A.A., Whitney W.R. The rate of solution of solid substances in their own solutions. Journal of the American Chemical Society 1897, 19:930-934.
46. Peppas N.A., Colombo P. Analysis of drug release behavior from swellable polymer carriers using the dimensionality index. Journal of Controlled Release 1997, 5:35-40.
47. Pereira R.R.A., Godoy J.S.R., Svidzinski T.I.E., Bruschi M.L. Preparation and characterization of mucoadhesive thermoresponsive systems containing propolis for the treatment of vulvovaginal candidiasis. Journal of Pharmaceutical Sciences 2013, 102(4):1222-1234.
48. Philibert J. One and a half century of diffusion: Fick, Einstein, before and beyond. Diffusion Fundamentals 2005, 2:1.1-1.10.
49. Rejmanova P., Kopecek J., Pohl J., Baudys M., Kostka V. Polymers containing enzymatically degradable bonds. Degradation of oligopeptide sequences in N-(1992-hydroxypropyl)methacrylamide co-polymers by bovine spleen cathepsin-B. Macromolecular Chemistry and Physics 1983, 184:2009-2020.
50. Ringsdorf H. Structure and properties of pharmacologically active polymers. Journal of Polymer Science 1975, 51:135-153.
51. Ritschel W.A. Pharmacocinetic and biopharmaceutical aspects in drug delivery. Drug delivery devices: Fundamentals and applications 1988, 17-80. Marcel Dekker, New York. P. Tyle (Ed.).
52. Schmitt, E., & Polistina, R. (1967). Surgical sutures, US Patent 3,297,033.
53. Stigi J.F. The regulation of drug delivery devices. Drug delivery devices: Fundamentals and applications 1988, 81-133. Marcel Dekker, New York. P. Tyle (Ed.).
54. Theeuwes, F., Calif, L.A., Higuchi, T., Kans, L. (1974). Osmotic dispensing device for releasing beneficial agent. US Patent 3,845,770.
55. USP United States Pharmacopoeia 37-National Formulary 32 2014, US Pharmacopoeial Convention, Rockville.
56. Westedt U., Wittmar M., Hellwig M., Hanefeld P., Greiner A., Schaper A.K., et al. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings. Journal of Controlled Release 2006, 111:235-246.
57. Wise D.L. Handbook of pharmaceutical controlled release technology 2000, CRC Press, New York.
58. Yun Y., Lee B.K., Park K. Controlled drug delivery systems: the next 30 years. Frontiers of Chemical Science and Engineering 2014, 8(3):276-279.
59. Zaffaroni, A., & Calif, A. (1971). Bandage for administering drugs, US Patent 3,598,122.
60. Bruschi M.L., Jones D., Panzeri H., Gremião M.P.D., De Freitas O., Lara E.H.G. Semisolid systems containing propolis for the treatment of periodontal disease: In vitro release kinetics, syringeability, rheological, textural, and mucoadhesive properties. Journal of Pharmaceutical Sciences 2007, 96(8):2074-2089.
61. Bruschi M.L., Jones D., Panzeri H., Gremião M.P.D., De Freitas O., Jones D.S., et al. Precursor system of liquid crystalline phase containing propolis microparticles for the treatment of periodontal disease: Development and characterization. Drug Development and Industrial Pharmacy 2008, 34:267-278.
62. Chan A., Orme R.P., Fricker R.A., Roach P. Remote and local control of stimuli responsive materials for therapeutic applications. Advanced Drug Delivery Reviews 2013, 65:497-514.
63. Ciach T., Moscicka-Studzinska M. Buccal iontophoresis: An opportunity for drug delivery and metabolite monitoring. Drug Delivery Today 2011, 16(7/8):361-366.
64. Edelman E., Kost J., Bobeck H., Langer R. Regulation of drug release from polymer matrices by oscillating magnetic fields. Journal of Biomedical Materials Research 1985, 19:67.
65. Farmer T.G., Edgar T.F., Peppas N.A. The future of open and closed-loop insulin delivery for diabetes mellitus. Journal of Pharmacy and Pharmacology 2008, 60(1):1-13.
66. Heilmann K. Therapeutic systems-Pattern-specific drug delivery: Concept and development 1978, Thieme, Stuttgart.
67. Heller J., Trescony P.V. Controlled drug release by polymer dissolution. II. An enzyme mediated delivery system. Journal of Pharmaceutical Sciences 1979, 68:919-921.
68. Jadoul A., Bouwstra J., Préat V. Effects of iontophoresis and electroporation on the stratum corneum. Review of the biophysical studies. Advanced Drug Delivery Reviews 1999, 35:89-105.
69. Jain K.K. Drug delivery systems 2008, Humana Press, Totowa.
70. Jain R.K. Delivery of molecular and cellular medicine to solid tumors. Advanced Drug Delivery Reviews 2012, 1(64) (Suppl):353-365.
71. Jeong S.Y., Kim S.W., Eenink M.J.D., Feijen J. Self-regulating insulin delivery systems I. Synthesis and characterization of glycosylated insulin. Journal of Controlled Release 1984, 1:57-66.
72. Jeong S.Y., Kim S.W., Holemberg D., McRea J.C. Self-regulating insulin delivery systems. III. In vivo studies. Journal of Controlled Release 1985, 2:143-152.
73. Jones D.S., Bruschi M.L., De Freitas O., Gremião M.P.D., Lara E.H.G., Andrews G.P. Rheological, mechanical and mucoadhesive properties of thermoresponsive, bioadhesive binary mixtures composed of poloxamer 407 and Carbopol 934PR designed as platforms for implantable drug delivery systems for use in the oral cavity. International Journal of Pharmaceutics 2009, 372:49-58.
74. Kost J., Langer R. Responsive polymeric delivery systems. Advanced Drug Delivery Reviews 2012, 64:327-341.
75. Kost J., Wolfrum J., Langer R. Magnetically enhanced insulin release in diabetic rats. Journal of Biomedical Materials Research 1987, 21:1367.
76. Ottenbrite R.M., Kim S.W. Polymeric drugs and drug delivery systems 2002, CRC Press, Boca Raton.
77. Pereira R.R.A., Godoy J.S.R., Svidzinski T.I.S., Bruschi M.L. Preparation and characterization of mucoadhesive thermoresponsive systems containing propolis for the treatment of vulvovaginal candidiasis. Journal of Pharmaceutical Sciences 2013, 102(4):1222-1234.
78. Saslawski O., Weigarten C., Benoit J.P., Couvreur P. Magnetically responsive microspheres for pulsed delivery of insulin. Life Sciences 1988, 42:1521.
79. Shim M.S., Kwon Y.J. Stimuli-responsive polymers and nanomaterials for gene delivery and imaging applications. Advanced Drug Delivery Reviews 2012, 64:1046-1059.
80. Amkraut A., Eckenhoff J.B., Nichols K. Osmotic delivery of peptides and macromolecules. Advanced Drug Delivery Reviews 1990, 4:255-276.
81. Aoki T., et al. A multicenter phase I/II study of the BCNU implant (Gliadel® wafer) for Japanese patients with malignant gliomas. Neurologia Medico-Chirurgica 2014, 54:290-301.
82. Bae Y.H., Park K. Targeted drug delivery to tumors: Myths, reality and possibility. Journal of Controlled Release 2011, 153:198-205.
83. Bies C., Lehr C.-M., Woodley J.F. Lectin-mediated drug targeting: History and applications. Advanced Drug Delivery Reviews 2004, 56:425-435.
84. Bruschi M.L., de Freitas O. Oral bioadhesive drug delivery systems. Drug Development and Industrial Pharmacy 2005, 31:293-310.
85. Colombo P. Swelling-controlled release in hydrogel matrices for oral route. Advanced Drug Delivery Reviews 1993, 11:37-57.
86. Crank J. The mathematics of diffusion 1975, Claredon Press, Oxford. 2nd ed.
87. Ehrlich P. The partial function of cells. International Archives of Allergy and Applied Immunology 1954, 5:67-86.
88. Fan L.T., Singh S.K. Controlled release: Aquantitative treatment 1989, Springer, Berlin.
89. Fang J., Nakamura H., Maeda H. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Advanced Drug Delivery Reviews 2011, 63:136-151.
90. Florence A.T., Attwood D. Physicochemical principles of pharmacy 2006, Pharmaceutical Press, London. 4th ed.
91. Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspensions. Journal of Pharmaceutical Sciences 1961, 50:874-875.
92. Higuchi W.I. Analysis of data on the medicament release from ointments. Journal of Pharmaceutical Sciences 1962, 51(8):802-804.
93. Hillery A.M., Lloyd A.W., Swarbrick J. Drug delivery and targeting for pharmacists and pharmaceutical scientists 2001, Taylor & Francis, Oxford.
94. Lammers T., Kiessling F., Hennink W.E., Storm G. Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress. Journal of Controlled Release 2012, 161:175-187.
95. Maeda H., Wu J., Sawa T., Matsumara Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. Journal of Controlled Release 2000, 65:271-284.
96. Mathiowitz E. Encyclopedia of controlled drug delivery 1999, Wiley, New York.
97. Matsumura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS. Cancer Research 1986, 46:6387-6392.
98. Mills J.K., Needham D. Targeted drug delivery. Expert Opinion on Therapeutic Patents 1999, 9:1499-1513.
99. Omidian H., Park K. Swelling agents and devices in oral drug delivery. Journal of Drug Delivery Science and Technology 2008, 18(2):83-93.
100. Ottenbrite R.M., Kim S.W. Polymeric drugs and drug delivery systems 2002, CRC Press, Boca Raton.
101. Peppas N.A., Narasimhan B. Mathematical models in drug delivery: How modeling has shaped the way we design new drug delivery systems. Journal of Controlled Release 2014, 190:75-81.
102. Perrie Y., Rades T. Pharmaceutics: Drug delivery and targeting 2010, Pharmaceutical Press, London.
103. Petrak K. Essential properties of drug-targeting delivery systems. Drug Discovery Today 2005, 10(23/24):1667-1673.
104. Ruenraroengsak P., Cook J.M., Florence A.T. Nanosystem drug targeting: Facing up to complex realities. Journal of Controlled Release 2010, 141:265-276.
105. Siegel R.A., Rathbone M.J. Overview of controlled release mechanisms. Fundamentals and applications of controlled release drug delivery 2012, 19-46. Springer, New York. J. Siepmann, R.A. Siegel, M.J. Rathbone (Eds.).
106. Theeuwes F. Elementary osmotic pump. Journal of Pharmaceutical Sciences 1975, 64:1987-1991.
107. Theeuwes, F., & Ayer, A.D. (1978), U.S. Pat. 4,077,407, to ALZA Corp.
108. Vyas S.P., et al. Ligand-receptor-mediated drug delivery: An emerging paradigm in cellular drug targeting. Critical Reviews in Therapeutic Drug Carrier Systems 2001, 18(l):1-76.
109. Wang B., Siahaan T., Soltero R.A. Drug delivery: Principles and applications 2005, Wiley, Hoboken.
110. Wilson C.G., Crowley P.J. Controlled release in oral drug delivery 2011, Springer, London.
111. Agnes E.J., Gonzales Ortega G. Mathematical models and physicochemical of diffusion. Pharmacy Book 2003, 19(1):9-19.
112. Alfrey T., Gurnee E.F., Lloyd W.G. Diffusion in glassy polymers. Journal of Polymer Science 1966, C12:249-261.
113. Baker R.W., Lonsdale H.S. Controlled release: mechanisms and rates. Controlled release of biologically active agents 1974, 15-71. Plenum, New York. A.C. Taquary, R.E. Lacey (Eds.).
114. Costa P. An alternative method to the evaluation of similarity factor in dissolution testing. International Journal of Pharmaceutics 2001, 220:77-83.
115. Dash S., Murthy P.N., Nath L., Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Poloniae Pharmaceutica 2010, 67(3):217-223.
116. El-Arini S.K., Leuenberger H. Dissolution properties of praziquantel-PVP systems. Pharmaceutica Acta Helvetiae 1998, 73:89-94.
117. Ford J.L., Mitchell K., Rowe P., Armstrong D.J., Elliot P.N.C., Rostron C., et al. Mathematical modeling of drug release from hydroxypropylmethylcellulose: Effect of temperature. International Journal of Pharmaceutics 1991, 71:95-104.
118. Higuchi T. Rate of release of medicaments from ointments bases containing drugs in suspension. Journal of Pharmaceutical Sciences 1961, 50(10):874-875.
119. Higuchi W.I. Analysis of data on the medicament release from ointments. Journal of Pharmaceutical Sciences 1962, 51(8):802-804.
120. Higuchi T. Mechanism of sustained-action medication. Journal of Pharmaceutical Sciences 1963, 52(12):1145-1149.
121. Hixson A.W., Crowell J.H. Dependence of reaction velocity upon surface and agitation: I-Theoretical consideration. Industrial and Engineering Chemistry 1931, 23:923-931.
122. Katzhendler I., Hofman A., Goldberger A., Friedman M. Modeling of drug release from erodible tablets. Journal of Pharmaceutical Sciences 1997, 86:110-115.
123. Kim H., Fassihi R. Application of binary polymer in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics. Journal of Pharmaceutical Sciences 1997, 86(3):323-328.
124. Klech C.M., Simonelli A.P. Examination of the moving boundaries associated with non-Fickian water swelling of glassy gelatin beads: Effect of solution pH. Journal of Membrane Science 1989, 43:87-101.
125. Korsmeyer R.W., Gurny R., Doelker E.M., Buri P., Peppas N.A. Mechanism of solute release from porous hydrophilic polymers. International Journal of Pharmaceutics 1983, 15:25-35.
126. Kosmidis K., Argyrakis P., Macheras p. Fractal kinetics in drug release from finite fractal matrices. Journal of Chemical Physics 2003, 119:6373-6377.
127. Langenbucher F. Linearization of dissolution rate curves by the Weibull distribution. Journal of Pharmacy and Pharmacology 1972, 24:979-981.
128. Langer R.S., Peppas N.A. Chemical and physical structure of polymers as carriers for controlled release of bioactive agents: A review. Journal of Macromolecular Science - Reviews in Macromolecular Chemistry and Physics 1983, C23(1):61-126.
129. Mauger J.W., Chilko D., Howard S. On the analysis of the dissolution data. Drug Development and Industrial Pharmacy 1986, 12:969-992.
130. Narasimhan B., Peppas N.A. The role of modeling studies in the development of future controlled-release devices. Controlled drug delivery 1997, 529-558. ACS, Washington. K. Park (Ed.).
131. Noyes A.A., Whitney W.R. The rate of solution of solid substances in their own solutions. Journal of the American Chemical Society 1897, 19:930-934.
132. O'Hara T., Dunne A., Butler J., Devane J. A review of methods used to compare dissolution profile data. Pharmaceutical Science and Technology Today 1998, 1:214-223.
133. Omidian H., Park K. Introduction to hydrogels. Biomedical applications of hydrogels handbook 2010, 1-16. Springer, New York. R.M. Ottenbrite, K. Park, T. Okano (Eds.).
134. Peppas N.A. Analysis of Fickian and non-Fickian drug release from polymers. Pharmaceutica Acta Helvetiae 1985, 60:110-111.
135. Peppas N.A., Narasimhan B. Mathematical models in drug delivery: How modeling has shaped the way we design new drug delivery systems. Journal of Controlled Release 2014, 190:75-81.
136. Peppas N.A., Sahlin J.J. A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. International Journal of Pharmaceutics 1989, 57:169-172.
137. Pillay V., Fassihi R. In vitro release modulation from crosslinked pellets for site-specifric drug delivery to the gastrointestinal tract. Journal of Controlled Release 1999, 59:229-242.
138. Polli J.E., Rekhi G.S., Augsburger L.L., Shah V.P. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. Journal of Pharmaceutical Sciences 1997, 86:690-700.
139. Ritger P.L., Peppas N.A. A simple equation for describing of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. Journal of Controlled Release 1987, 5:23-36.
140. Seki T., Kawaguchi T., Endoh H., Ishikawa K., Juni K., Nakano M. Controlled release of 3,5-diester prodrugs of 5-fluoro-2-deoxyuridine from poly-l-lactic acid microspheres. Journal of Pharmaceutical Sciences 1980, 19:985-987.
141. Sibanda W., Pillay V., Danckwerts M.P., Viljoen A.M., van Vuuren S., Khan R.A. Experimental design for the formulation and optimization of novel cross-linked oilispheres developed for in vitro site-specific release of mentha piperita oil. AAPS PharmSciTech 2004, 5:18.
142. Siepmann J., Peppas N.A. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Advanced Drug Delivery Reviews 2012, 64:163-174.
143. Walters K.A., Brain K.R. Dermatological formulation and transdermal systems. Dermatological and transdermal formulations 2009, 319-400. Informa, New York. K.A. Waletrs (Ed.).
144. Weilbull W. A statistical distribution function of wide applicability. Journal of Applied Mechanics 1951, 18:293-297.
145. Zhang J., Fub M., Zhang M., Xua L., Gao Y. Synthesis of oxidized glycerol monooleate-chitosan polymer and its hydrogel formation for sustained release of trimetazidine hydrochloride. International Journal of Pharmaceutics 2014, 465:32-41.
146. Zhang Y., Huo M., Zhou J., Zou A., Li W., Yao C., et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. The AAPS Journal 2010, 12:263-271.
147. Abu-Diak O.A., Andrews G.P., Jones D.S. Hydrophobic polymers of pharmaceutical significance. Fundamentals and applications of controlled release drug delivery 2012, 47-73. New York, Springer. J. Siepmann, R.A. Siegel, M.J. Rathbone (Eds.).
148. Allen T.M., Cullis T.R. Liposomal drug delivery systems: From concept to clinical applications. Advanced Drug Delivery Reviews 2013, 65:36-48.
149. Allen L.V., Popovich N.G., Ansel H.C. Ansel's pharmaceutical dosage forms and drug delivery 2011, Lippincott Williams & Wilkins, Baltimore-Philadelphia, 1-710.
150. Amkraut A., Eckenhoff J.B., Nichols K. Osmotic delivery of peptides and macromolecules. Advanced Drug Delivery Reviews 1990, 4:255-276.
151. Atwood D. Disperse systems. Pharmaceutics: The science of dosage form design 2001, 91-93. Churchill Livingstone, London. 2nd ed. M.E. Aulton (Ed.).
152. Azagury A., Khoury L., Enden G., Kost J. Ultrasound mediated transdermal drug delivery. Advanced Drug Delivery Reviews 2014, 72:127-143.
153. Bangham A.D., Standish M.M., Watkins J.C. Diffusion of univalent ions across the lamellae of swollen phospholipids. Journal of Molecular Biology 1965, 13:238-252.
154. Banker G.S., Anderson N.S. Tablets. The theory and practice of industrial pharmacy 2001, 509-597. Fundation Calouste Gulbekian, Lisbon. L. Lachman, H.A. Lieberman, J.L. Kanig (Eds.).
155. Bansal V., Malviya R., Malaviya T., Sharma P.K. Novel prospective in colon specific drug delivery system. Polimery w Medycynie 2014, 44(2):109-118.
156. Bardonnet P.L., Faivre V., Pugh W.J., Piffaretti J.C., Falson F. Gastroretentive dosage forms: Overview and special case of Helicobacter pylori. Journal of Controlled Release 2006, 111:1-18.
157. Benita S. Microencapsulation-Methods and industrial applications 2006, (pp. 1-741), CRC Press, Boca Raton.
158. Bourges J.L., Bloquel C., Thomas A., Froussart F., Bochot A., Azan F., et al. Intraocular implants for extended drug delivery: Therapeutic applications. Advanced Drug Delivery Reviews 2006, 58:1182-1202.
159. Brandau T. Preparation of monodisperse controlled release microcapsules. International Journal of Pharmaceutics 2002, 242:179-184.
160. Bruschi M.L., de Freitas O. Oral bioadhesive drug delivery systems. Drug Development and Industrial Pharmacy 2005, 31(3):293-310.
161. Bruschi M.L., Jones D.S., Panzeri H., Gremião M.P.D., de Freitas O., Lara E.H.G. Semisolid systems containing propolis for the treatment of periodontal disease: In vitro release kinetics, syringeability, rheological, textural, and mucoadhesive properties. Journal of Pharmaceutical Sciences 2007, 96(8):2074-2089.
162. Bruschi M.L., Jones D.S., Panzeri H., Gremião M.P.D., Freitas O., Lara E.H.G. Development and characterization of precursor of liquid crystalline phase with propolis-containing microparticles for use in the treatment of periodontal disease. Drug Development and Industrial Pharmacy 2008, 34(3):267-278.
163. Buri P. Définition et classification des systèmes matriciels. STP Pharma 1987, 3(3):193-199.
164. Carvalho F.C., Bruschi M.L., Evangelista R.C., Gremião M.P.D. Mucoadhesive drug delivery systems. Brazilian Journal of Pharmaceutical Sciences 2010, 46(1):1-18.
165. Carvalho F.C., Campos M.L., Peccinini R.G., Gremião M.P. Nasal administration of liquid crystal precursor mucoadhesive vehicle as an alternative antiretroviral therapy. European Journal of Pharmaceutics and Biopharmaceutics 2013, 84(1):219-227.
166. Chang R.K. Formulation approaches for sustained release oral suspensions. Pharmaceutical Technology 1992, 16:134-136.
167. Chowdary C.P.R., Rao Y.S. Mucoadhesive microspheres for controlled drug delivery. Biological & Pharmaceutical Bulletin 2004, 27(11):1717-1724.
168. Chung J.E., Yokoyama M., Yamato M., Aoyagi T., Sakurai Y., Okano T. Thermoresponsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate). Journal of Controlled Release 1999, 62:115-127.
169. Collett J., Moreton C. Modified-release peroral dosage form. Pharmaceutics: The science of dosage form design 2001, 289-306. Churchill Livingstone, London. 2nd ed. M.E. Aulton (Ed.).
170. Danielsson I., Lindamn B. The definition of microemulsion. Colloids Surfaces 1981, 3:391-392.
171. Dash T.R., Verma P. Matrix tablets: An approach towards oral extended release drug delivery. International Journal of Pharma Research & Review 2013, 2(2):12-24.
172. Falkiewicz M.J. Theory of suspensions. Pharmaceutical dosage forms: Disperse systems 1996, Vol. 1:17-50. Marcel Dekker, New York. 2nd ed. H.A. Lieberman, M.M. Rieger, G.S. Banker (Eds.).
173. Fara J.W., Ray N. Osmotic pumps. Drug delivery devices 1988, 137-175. Marcel Dekker, New York. P. Tyle (Ed.).
174. Ferrero C., Massuelle D., Doelker E. Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. II. Evaluation of a possible swelling-controlled drug release mechanism using dimensionless analysis. Journal of Controlled Release 2010, 141:223-233.
175. Ferrero C., Massuelle D., Jeannerat D., Doelker E. Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. I. Pulse-field-gradient spin-echo NMR study of sodium salicylate diffusivity in swollen hydrogels with respect to polymer matrix physical structure. Journal of Controlled Release 2008, 128:71-79.
176. Ferrero C., Massuelle D., Jeannerat D., Doelker E. Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. III. Critical use of thermodynamic parameters of activation for modeling the water penetration and drug release processes. Journal of Controlled Release 2013, 170:175-182.
177. Florence A.T., Attwood D. Physicochemical principles of pharmacy 2006, Pharmaceutical Press, London, 1-492. 4th ed.
178. Friend R.D. New oral delivery systems for treatment of inflammatory bowel disease. Advanced Drug Delivery Reviews 2004, 57:247-265.
179. Gao P., Rush B.D., Pfund W.P., Huang T., Bauer J.M., Morozowich W., et al. Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. Journal of Pharmaceutical Sciences 2003, 92:2386-2398.
180. Ghosh T., Ghosh A. Drug delivery through osmotic systems-an overview. Journal of Applied Pharmaceutical Science 2011, 1(2):38-49.
181. Gustafsson, J., Ljusberg-Wahren, H., Almgren, M., & Larsson, K. (1996). Cubic lipid-water.
182. Hägerström H., Edsman K., Strømme M. Low- frequency dielectric spectroscopy as a tool for studying the compatibility between pharmaceutical gels and mucus tissue. Journal of Pharmaceutical Sciences 2003, 92(9):1869-1881.
183. Higuchi T. Rate of release of medicaments from ointments bases containing drugs in suspension. Journal of Pharmaceutical Sciences 1961, 50(10):874-875.
184. Higuchi W.I. Analysis of data on the medicament release from ointments. Journal of Pharmaceutical Sciences 1962, 51(8):802-804.
185. Higuchi T. Mechanism of sustained-action medication. Journal of Pharmaceutical Sciences 1963, 52(12):1145-1149.
186. Higuchi, T. & Leeper, H.M. (1973). ALZA Corp., assignee. Osmotic dispenser. US Patent 3,732,865.
187. Hoar T.P., Schulman J.H. Transparent water in oil dispersions: Oleopathic hydromicelle. Nature 1943, 152:102.
188. Ichikawa M., Watanabe S., Miyake Y. A new multiple-unit oral floating dosage system. I: Preparation and in vitro evaluation of floating and sustained-release characteristics. Journal of Pharmaceutical Sciences 1991, 80(11):1062-1066.
189. International Union of Pure and Applied Chemistry Manual of colloid science 1972, Butterworth, London.
190. Jain N.K. Controlled and novel drug delivery 1997, CBS Publisher, New Delhi, 236-237.
191. Jamekhorshid A., Sadrameli S.M., Farid M. A review of microencapsulation methods of phase change materials (PCMs) as a thermal energy storage (TES) medium. Renewable & Sustainable Energy Reviews 2014, 31:531-542.
192. Jones D.S. Pharmaceutics-Dosage form and design 2008, Pharmaceutical Press, London, pp. 25-42.
193. Jones D.S., Bruschi M.L., Freitas O., Gremião M.P.D., Lara E.H.G., Andrews G.P. Rheological, mechanical and mucoadhesive properties of thermoresponsive, bioadhesive binary mixtures composed of poloxamer 407 and carbopol 934P designed as platforms for implantable drug delivery systems for use in the oral cavity. International Journal of Pharmaceutics 2009, 372:49-58.
194. Kim Y.-C., Park J.-H., Prausnitz M.R. Microneedles for drug and vaccine delivery. Advanced Drug Delivery Reviews 2012, 64(14):1547-1568.
195. Kreilgaard M. Influence of microemulsions on cutaneous drug delivery. Advanced Drug Delivery Reviews 2002, 54(S1):S77-S98.
196. Kurkov S.V., Loftsson T. Cyclodextrins. International Journal of Pharmaceutics 2013, 453:167-180.
197. Langer R. Transdermal drug delivery: Past progress, current status, and future prospects. Advanced Drug Delivery Reviews 2004, 56:557-558.
198. Lawrence M.J., Rees G.D. Microemulsion-based media as novel drug delivery systems. Advanced Drug Delivery Reviews 2012, 64(S):175-193.
199. Lee J.W., Park J.H., Robinson J.R. Bioadhesive-based dosage forms: The next generation. Journal of Pharmaceutical Sciences 2000, 89(7):850-866.
200. Lehr C.M. Lectin-mediated drug delivery: The second generation of bioadhesives. Journal of Controlled Release 2000, 65(1):19-29.
201. Loftsson T., Duchêne D. Cyclodextrins and their pharmaceutical applications. International Journal of Pharmaceutics 2007, 329:1-11.
202. Lovelyn C., Attama A.A. Current state of nanoemulsions in drug delivery. Journal of Biomaterials and Nanobiotechnology 2011, 2:626-639.
203. Masataka K., Watanabe S., Takemura S., Sako K., Sawada T., Masuda Y., et al. Scintigraphic evaluation of a novel colon-targeted delivery system (CODESTM) in healthy volunteers. Journal of Pharmaceutical Sciences 2004, 93(5):1287-1299.
204. Mason T.G., Wilking J.N., Meleson K., Chang C.B., Graves S.M. Nanoemulsions: Formation, structure, and physical properties. Journal of Physics.. Condensed Matter 2006, 18:R635-R666.
205. McClements D.J. Nanoemulsions versus microemulsions: Terminology, differences, and similarities. Soft Matter 2012, 8:1719-1729.
206. Miyazaki S., Yokouchi D., Nakamura T., Hashigushi N., Hou W.M., Takada M. Pluronic F-127 gels as a novel vehicle for rectal administration of indomethacin. Chemical & Pharmaceutical Bulletin 1986, 34:1801-1808.
207. Moghassemi S., Hadjizadeh A. Nano-niosomes as nanoscale drug delivery systems: An illustrated review. Journal of Controlled Release 2014, 185:22-36.
208. Muller-Goymann C.C., Hamann H.-J. Sustained release from reverse micellar solutions by phase transformations into lamellar liquid crystals. Journal of Controlled Release 1993, 23:165-174.
209. Munday D.C., Cox P.J. Compressed xanthan and karaya gum matrices: Hydration, erosion and drug release mechanisms. International Journal of Pharmaceutics 2000, 203:179-192.
210. Nagai T. Adhesive topical drug delivery system. Journal of Controlled Release 1985, 2:121-134.
211. Nagai T., Nishimoto Y., Nambu N., Suzuki Y., Sekine K. Powder dosage form of insulin for nasal administration. Journal of Controlled Release 1984, 1(1):15-22.
212. Nash R.A. Pharmaceutical suspensions. Pharmaceutical dosage forms: Disperse systems 1988, Vol. 1:151. Marcel Dekker, New York. H.A. Lieberman, M.M. Rieger, G.S. Banker (Eds.).
213. Ochoa M., Mousoulis C., Ziaie B. Polymeric microdevices for transdermal and subcutaneous drug delivery. Advanced Drug Delivery Reviews 2012, 64(14):1603-1616.
214. Olsen K.M., Hitzeman M.L. Dexlansoprazole MR in the management of gastroesophageal reflux disease. Clinical Medicine: Therapeutics 2009, 1:1641-1652.
215. Pan X., Han K., Peng X., Yang Z., Qin L., Zhu C., et al. Nanostructed cubosomes as advanced drug delivery system. Current Pharmaceutical Design 2013, 19:6290-6297.
216. Patil N.S., Dordick J.S., Rethwisch D.G. Macroporous poly(sucrose acrylate) hydrogel for controlled release of macromolecules. Biomaterials 1996, 17:2343-2350.
217. Peppas N.A., Buri P.A. Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissue. Journal of Controlled Release 1985, 2:257-275.
218. Pereira R.R.A., Godoy J.S.R., Svidzinski T.I.E., Bruschi M.L. preparation and characterization of mucoadhesive thermoresponsive systems containing propolis for the treatment of vulvovaginal candidiasis. Journal of Pharmaceutical Sciences 2013, 102(4):1222-1234.
219. Prince L.M. A Theory of aqueous emulsions-I. Negative interfacial tension at the oil/water interface. Journal of Colloid and Interface Science 1967, 23:165-173.
220. Reineke J., Cho D.Y., Dingle Y.L., Cheifetz P., Laulicht B., Lavin D., et al. Can bioadhesive nanoparticles allow for more effective particle uptake from the small intestine?. Journal of Controlled Release 2013, 170:477-484.
221. Rogers T.L., Hu J., Yu Z., Johnston K.P., Williams R.O. A novel particle engineering technology: Spray-freezing into liquid. International Journal of Pharmaceutics 2002, 242(1-2):93-100.
222. Rose S., Nelson J.F. A continuous long-term injector. The Australian Journal of Experimental Biology and Medical Science 1955, 33(4):415-419.
223. Rowe C.R., Sheskey P.J., Quinn M.E. Handbook of pharmaceutical excipients 2009, Pharmaceutical Press, London. 6th ed.
224. Santus G., Baker R.W. Osmotic drug delivery: A review of the patent literature. Journal of Controlled Release 1995, 35:1-21.
225. Savic S., SaviC M., Tamburic S., Vuleta G., Vesic S., Müller-Goymanne C. An alkylpolyglucoside surfactant as a prospective pharmaceutical excipient for topical formulations: The influence of oil polarity on the colloidal structure and hydrocortisone in vitro/in vivo permeation. European Journal of Pharmaceutical Sciences 2007, 30:441-450.
226. Scherlund M., Malmsten M., Holmqvist P., Brodin A. Thermosetting microemulsions as delivery systems for periodontal anesthesia. International Journal of Pharmaceutics 2000, 194:103-116.
227. Schulman J.H., Stoeckenius W., Prince L.M. Mechanism of formation and structure of microemulsions by electron microscopy. Journal of Physical Chemistry 1959, 63:1677-1680.
228. Siepmann J., Peppas N.A. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Advanced Drug Delivery Reviews 2001, 48(2-3):139-157.
229. Smart J.D. The basics and underlying mechanisms of mucoadhesion. Advanced Drug Delivery Reviews 2005, 57(11):1556-1568.
230. Solans C., Solé I. Nano-emulsions: Formation by low-energy methods. Current Opinion in Colloid & Interface Science 2012, 17:246-254.
231. Stegemann S. Capsules as a delivery system for modified-release products. Controlled release in oral drug delivery 2011, 277-298. Springer, London. C.G. Wilson, P.J. Crowley (Eds.).
232. Stella V.J., He Q. Cyclodextrins. Toxicologic Pathology 2008, 36:30-42.
233. Tadros T.F., Izquierdo P., Esquena J., Solans C. Formation and stability of nano-emulsions. Advances in Colloid and Interface Science 2004, 108-109:303-318.
234. Theeuwes F. Elementary osmotic pump. Journal of Pharmaceutical Sciences 1975, 64(12):1987-1991.
235. Theeuwes, F., & Higuchi, T. (1974). ALZA Corp., assignee. Osmotic dispensing device for releasing beneficial agent. US Patent 3,845,770.
236. Theeuwes F., Swanson D.R., Guittard G., Ayer A., Khanna S. Osmotic delivery systems for the β-adrenoceptor antagonists metoprolol and oxprenolol: Design and evaluation of systems for once-daily administration. British Journal of Clinical Pharmacology 1985, 19(Suppl.):69S-76S.
237. Theeuwes F., Yum S.I. Principles of the design and operation of generic osmotic pumps for the delivery of semisolid or liquid drug formulations. Annals of Biomedical Engineering 1976, 4(4):343-353.
238. Timmermans J., Andre J.M. Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: New data for reconsidering the controversy. Journal of Pharmaceutical Sciences 1994, 83:18-24.
239. Timmermans J., Moes A.J. How well do floating dosage forms float. International Journal of Pharmaceutics 1990, 62:207-216.
240. Uchegbu F.I., Suresh V.P. Non-ionic surfactant based vesicles (niosomes) in drug delivery. International Journal of Pharmaceutics 1998, 172:33-70.
241. Veiga F.J.B. Oral medicines of controlled release. Boletim da Faculdade de Farmacia de Coimbra 1988, 12(2):17-87.
242. Verma R.K., Arora S., Garg S. Osmotic pumps in drug delivery. Critical Reviews in Therapeutic Drug Carrier Systems 2004, 21(6):477-520.
243. Vicentini F.T.M.C., Depieri L.V., Polizello A.N.M., Del Ciampo J.O., Spadaro A.C.C., Fantini M.C.A., et al. Liquid crystalline phase nanodispersions enable skin delivery of siRNA. European Journal of Pharmaceutics and Biopharmaceutics 2013, 83:16-24.
244. Villiers A. Sur la fermentation de la fecule par l'action du ferment butyrique. Comptes Rendus de l'Académie des Sciences 1891, 112:536-538.
245. Williams A.C., Barry B.W. Penetration enhancers. Advanced Drug Delivery Reviews 2004, 56:603-618.
246. Winsor P.A. Hydrotropy, solubilisation and related emulsification processes. Transactions of the Faraday Society 1948, 44:376-398.
247. Woodley J. Bioadhesion, new possibilities for drug administration?. Clinical Pharmacokinetics 2001, 40(2):77-84.
248. Wright J.C., Leonard S.T., Stevenson C.L., Beck J.C., Chen G., Jao R.M., et al. An in vivo/in vitro comparison with a leuprolide osmotic implant for the treatment of prostate cancer. Journal of Controlled Release 2001, 75:1-10.
249. Wright J.C., Stevenson C.L. Pumps/osmotic-introduction. Encyclopedia of controlled drug delivery 1999, John Wiley, New York. E. Mathiowitz (Ed.).
250. Yuan J., Liu T., Li H., Shi T., Xu J., Liu H., et al. Oral sustained-release suspension based on a novel taste-masked and mucoadhesive carrier-ion-exchange fiber. International Journal of Pharmaceutics 2014, 472:74-81.
251. Zhang J., Ma P.X. Cyclodextrin-based supramolecular systems for drug delivery: Recent progress and future perspective. Advanced Drug Delivery Reviews 2013, 65:1215-1233.